Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of JTE-052 (delgocitinib) ointment in atopic dermatitis
jRCT2080222835Phase 2Completed
- Sponsor
- Japan Tobacco
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing JTE-052 (delgocitinib) ointment with Placebo ointment (2 arms). Primary endpoint: Primary efficacy and safety outcomes. Started Apr 2015; status: completed.
02
Drugs
delgocitinib
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080222835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222835.